ACR Convergence 2024

November 14-19, 2024. Washington, DC.

View by Number View by Title View Sessions

Monday, November 18, 2024

10:30AM-12:30PM: Abstract Number: 2161

Parent and Youth Report of Psychosocial Functioning in Chronic Childhood Vasculitis

Patient Outcomes, Preferences, & Attitudes Poster III

10:30AM-12:30PM: Abstract Number: 2188

Parent Verses Patient Perspectives of Health-Related Quality of Life Among Children with Vasculitis

Pediatric Rheumatology – Clinical Poster III

10:30AM-12:30PM: Abstract Number: 2337

Patient Characteristics and Outcomes of Emergency Visits in Psoriatic Arthritis: Results from the U.S. Nationwide Emergency Department Sample (NEDS)

SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster III

10:30AM-12:30PM: Abstract Number: 2488

Patient Characteristics and Treatment Patterns Before and After Initiation of Avacopan in the United States: An Early View Based on a Claims Database Analysis

Vasculitis – ANCA-Associated Poster III

10:30AM-12:30PM: Abstract Number: 2101

Patient Characteristics Associated with Objectively-Assessed Physical Activity in Veterans with Knee Osteoarthritis

Osteoarthritis – Clinical Poster II

10:30AM-12:30PM: Abstract Number: 2095

Patient Perceptions of an Osteoarthritis Management Program at a Midwest Medical Center

Osteoarthritis – Clinical Poster II

10:30AM-12:30PM: Abstract Number: 2360

Patient Selection and Treatment Outcomes Using Preliminary Data-driven Definition versus the Established ASAS Definition of a Positive MRI of the Sacroiliac Joint in axSpA: Post-hoc Analysis from COAST-X

SpA Including PsA – Treatment Poster III

10:30AM-12:30PM: Abstract Number: 1951

Patient-Reported Barriers to Care Across Pediatric Rheumatology Patients at a Tertiary Academic Medical Center

Health Services Research – ACR/ARP Poster III

10:30AM-12:30PM: Abstract Number: 1915

Patient-reported Difficulties Regarding Reproductive Health Discussions in an Urban Outpatient Setting

Healthcare Disparities in Rheumatology Poster III

10:30AM-12:30PM: Abstract Number: 1919

Patient-reported Social Risk Factor Screening Among Rheumatology Outpatients

Healthcare Disparities in Rheumatology Poster III

10:30AM-12:30PM: Abstract Number: 2265

Patient’s Global Assessment of Disease Activity Is the Most Relevant Factor for Near-Miss of Boolean 2.0 Remission in Patients with Rheumatoid Arthritis: Post Hoc Analysis from the Observational UPwArds Study

RA – Treatment Poster III

10:30AM-12:30PM: Abstract Number: 1939

Patient’s Satisfaction with a Telerheumatology Program in a Remote Rural Area of Northern Pakistan

Health Services Research – ACR/ARP Poster III

10:30AM-12:30PM: Abstract Number: 2336

Patients with Psoriasis with a Positive Psoriasis Epidemiology Screening Tool (PEST): Similarities and Differences Compared to PsA and Patients with Psoriasis and a Negative PEST

SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster III

10:30AM-12:30PM: Abstract Number: 2182

PECOS (Pediatric SARS-CoV-2 MIS-C Long-term Outcomes Study): Preliminary Results

Pediatric Rheumatology – Clinical Poster III

10:30AM-12:30PM: Abstract Number: 2175

Pediatric Rheumatology Clinic Referral Patterns at a Large Midwestern Center

Pediatric Rheumatology – Clinical Poster III

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].